PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancerYunxing Shi(Sun Yat-sen University), Binkui Li(Sun Yat-sen University)Nature CommunicationsApril 6, 202310.1038/s41467-023-37542-5Cited by 81SaveCiteExport RISWatch citationsRelated PapersTargeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS/STING signaling|Nature Communications|2024|40Dynamic Arginine Methylation of YBX1 Relay Controls Its Phase Separation and Chemoradiotherapy Resistance in Rectal Cancer|Advanced Science|2025|1